Newborn Screening for Severe Combined Immunodeficiency.
Newborn screening (NBS)
Severe combined immunodeficiency (SCID)
T-cell lymphopenia
T-cell receptor excision circle (tREC)
Journal
Pediatric clinics of North America
ISSN: 1557-8240
Titre abrégé: Pediatr Clin North Am
Pays: United States
ID NLM: 0401126
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
entrez:
31
8
2019
pubmed:
31
8
2019
medline:
24
1
2020
Statut:
ppublish
Résumé
The T-cell receptor excision circle (TREC) assay is an effective screening tool for severe combined immunodeficiency (SCID). The TREC assay was designed to detect typical SCID and leaky SCID, but any condition causing low naïve T-cell counts will also be detected. Newborn screening for SCID using the TREC assay has proven itself to be highly sensitive and cost-efficient. This review covers the history of SCID newborn screening, elaborates on the SCID subtypes and TREC assay limitations, and discusses diagnostic and management considerations for infants with a positive screen.
Identifiants
pubmed: 31466681
pii: S0031-3955(19)30089-6
doi: 10.1016/j.pcl.2019.06.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
913-923Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.